Creating a national database for patients with hypoparathyroidism and pseudohypoparathyroidism in Italy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish and manage a multicenter national database that collects and analyzes clinical, genetic, and therapeutic data from patients diagnosed with hypoparathyroidism or pseudohypoparathyroidism across Italy. Involving 41 specialized clinical centers, the study will gather data over a 10-year period through both retrospective and prospective methods. The goal is to enhance understanding of these rare endocrine disorders by documenting a wide range of patient characteristics and treatment outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Cohort 1: chronic hypoparathyroidism (all etiological forms)
* Cohort 2: pseudohypoparathyroidism

Exclusion Criteria:

* None

Where it's running

• UO Endocrinologia e Malattie del Ricambio, Azienda Ospedaliero Universitaria di Ferrara, Sezione di Endocrinologia, Geriatria e Medicina Interna, Dipartimento di Scienze Mediche, Università degli Studi di Ferrara
  Ferrara, Italy Recruiting
• SOD Malattie del Metabolismo Minerale ed Osseo, Azienda Ospedaliero-Universitaria Careggi
  Florence, Italy Recruiting
• Donatello Bone Clinic, Casa di Cura Villa Donatello
  Sesto Fiorentino, Italy Recruiting
• IRCCS Materno-Infantile Burlo Garofolo
  Trieste, Italy Recruiting
• SC Pediatria e Pronto Soccorso Pediatrico - AOU SS. Antonio e Biagio e C. Arrigo
  Alessandria, Italy Not yet recruiting
• U.O.C. Endocrinologia, Azienda Ospedaliero Universitaria Policlinico Consorziale, Università degli Studi di Bari "Aldo Moro"
  Bari, Italy Not yet recruiting

Study contacts

• Study coordinator: Maria Luisa Brandi, MD, PhD
• Email: marialuisa@marialuisabrandi.it
• Phone: 0039-055-2336663

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• German Hypoparathyroidism Registry

  This registry in Germany collects information from adults with chronic hypoparathyroidism or pseudohypoparathyroidism to better understand how the condition affects people over time and to support future research.

  Recruiting University Hospital Augsburg · Augsburg, Bavaria · NCT07857460

• Encaleret for Chronic Hypoparathyroidism: Testing if it helps symptoms and safety

  This study tests whether taking encaleret pills can help people with chronic hypoparathyroidism, while being safe and tolerable.

  Recruiting at 5 sites Phase 3 Calcilytix Therapeutics, Inc., a BridgeBio company · Reno, Nevada and 4 other locations · NCT07805356

• Palopegteriparatide in adolescents with long-term hypoparathyroidism

  This study tests whether a once-daily palopegteriparatide shot helps adolescents with long‑standing hypoparathyroidism and whether it’s safe for them.

  Recruiting at 3 sites Phase 3 Ascendis Pharma A/S · Bron and 2 other locations · NCT07706764

• Canvuparatide vs placebo in adults with hypoparathyroidism

  This study tests whether weekly canvuparatide can help adults with hypoparathyroidism feel better and keep calcium levels steady compared with a placebo.

  Recruiting at 22 sites Phase 3 MBX Biosciences · Englewood, Colorado and 21 other locations · NCT07699471

• NIRAF-guided identification of parathyroids during thyroidectomy

  A wearable near-infrared autofluorescence device is being tested to help surgeons find and protect the parathyroid glands during thyroid surgery in adults.

  Recruiting Ss. Cyril and Methodius University of Skopje · Skopje · NCT07617584

• Pregnancy registry tracking outcomes after YORVIPATH exposure during pregnancy and breastfeeding

  This registry collects information from pregnant or breastfeeding people with hypoparathyroidism who took YORVIPATH to see if the exposure affects pregnancy, the baby, or infant outcomes through the first year of life.

  Recruiting Ascendis Pharma A/S · Morgantown, West Virginia · NCT07345494

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.